These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24843084)

  • 1. Results from RCTs in Sclerotherapy: European Guidelines for Sclerotherapy in Chronic Venous Disorders*.
    Pannier F; Rabe E;
    Phlebology; 2014 May; 29(1 suppl):39-44. PubMed ID: 24843084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications, contraindications and performance: European Guidelines for Sclerotherapy in Chronic Venous Disorders.
    Rabe E; Pannier F;
    Phlebology; 2014 May; 29(1 suppl):26-33. PubMed ID: 24843082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European guidelines for sclerotherapy in chronic venous disorders.
    Rabe E; Breu FX; Cavezzi A; Coleridge Smith P; Frullini A; Gillet JL; Guex JJ; Hamel-Desnos C; Kern P; Partsch B; Ramelet AA; Tessari L; Pannier F;
    Phlebology; 2014 Jul; 29(6):338-54. PubMed ID: 23559590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [European guidelines for sclerotherapy in chronic venous disorders].
    Kovacević J
    Acta Med Croatica; 2014 Oct; 68 Suppl 1():127-44. PubMed ID: 25327003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for sclerotherapy of varicose veins (ICD 10: I83.0, I83.1, I83.2, and I83.9).
    Rabe E; Pannier-Fischer F; Gerlach H; Breu FX; Guggenbichler S; Zabel M;
    Dermatol Surg; 2004 May; 30(5):687-93; discussion 693. PubMed ID: 15099309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerotherapy in venous malformation.
    Rabe E; Pannier F
    Phlebology; 2013 Mar; 28 Suppl 1():188-91. PubMed ID: 23482557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.
    Rabe E; Pannier F
    Dermatol Surg; 2010 Jun; 36 Suppl 2():968-75. PubMed ID: 20590702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
    Rabe E; Schliephake D; Otto J; Breu FX; Pannier F
    Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous disorders: treatment with sclerosant foam.
    Bergan J; Pascarella L; Mekenas L
    J Cardiovasc Surg (Torino); 2006 Feb; 47(1):9-18. PubMed ID: 16434941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infusion of foam sclerosants results in a distance-dependent procoagulant activity, haemoconcentration and elevation of D-dimer levels.
    Connor DE; Joseph JE; Exner T; Ma DD; Parsi K
    Phlebology; 2014 Dec; 29(10):677-87. PubMed ID: 24002013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results.
    Kakkos SK; Bountouroglou DG; Azzam M; Kalodiki E; Daskalopoulos M; Geroulakos G
    J Endovasc Ther; 2006 Jun; 13(3):357-64. PubMed ID: 16784324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):343-8. PubMed ID: 18922712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard guidelines for care: sclerotherapy in dermatology.
    Khunger N; Sacchidanand S
    Indian J Dermatol Venereol Leprol; 2011; 77(2):222-31. PubMed ID: 21393966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Media Damage Following Detergent Sclerotherapy Appears to be Secondary to the Induction of Inflammation and Apoptosis: An Immunohistochemical Study Elucidating Previous Histological Observations.
    Whiteley MS; Dos Santos SJ; Fernandez-Hart TJ; Lee CT; Li JM
    Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):421-8. PubMed ID: 26790396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.
    Gloviczki P; Comerota AJ; Dalsing MC; Eklof BG; Gillespie DL; Gloviczki ML; Lohr JM; McLafferty RB; Meissner MH; Murad MH; Padberg FT; Pappas PJ; Passman MA; Raffetto JD; Vasquez MA; Wakefield TW; ;
    J Vasc Surg; 2011 May; 53(5 Suppl):2S-48S. PubMed ID: 21536172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany.
    Breu FX; Guggenbichler S
    Dermatol Surg; 2004 May; 30(5):709-17; discussion 717. PubMed ID: 15099312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency.
    Yamaki T; Nozaki M; Iwasaka S
    Dermatol Surg; 2004 May; 30(5):718-22; discussion 722. PubMed ID: 15099313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and complications of sclerotherapy for venous malformations.
    Qiu Y; Chen H; Lin X; Hu X; Jin Y; Ma G
    Vasc Endovascular Surg; 2013 Aug; 47(6):454-61. PubMed ID: 23759722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant endothelin release in patients treated with foam sclerotherapy.
    Frullini A; Barsotti MC; Santoni T; Duranti E; Burchielli S; Di Stefano R
    Dermatol Surg; 2012 May; 38(5):741-7. PubMed ID: 22540861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.